“Healthcare consulting” covers an unusually broad range of work — hospital operations, payer strategy, pharma commercialization, digital health, and medical device regulatory support all fall under the same general label. For organizations trying to hire the right partner, that breadth is a problem: a firm excellent at health system revenue cycle work may have little relevant expertise for a medical device company navigating an FDA submission. Understanding the difference between general healthcare consulting firms and specialized medtech consulting is often the first real decision point in a search for outside help.
This article explains what each category typically covers, how to decide which one fits your situation, and what to look for when evaluating a partner.
What Do Healthcare Consulting Firms Do?
Healthcare consulting firms generally serve providers (hospitals and health systems), payers (insurers), and life sciences companies, with services spanning strategy, operations improvement, technology implementation, M&A diligence, and regulatory compliance. The sector includes everything from large multinational strategy firms with dedicated healthcare practices to boutique advisory firms focused narrowly on one sub-sector, such as pharma commercialization or hospital revenue cycle management.
Because the category is so broad, firm positioning varies enormously. Some operate across the entire healthcare landscape — providers, payers, and life sciences alike — while others deliberately narrow their focus to one segment, such as biopharma strategy or health system operations, in order to build deeper domain expertise.
What Makes Medtech Consulting Different?
Medtech consulting is a specialized subset focused specifically on medical device and diagnostics companies, and it centers on a different set of problems than general healthcare consulting: FDA regulatory pathway strategy (510(k), De Novo, PMA), quality management system design (ISO 13485, FDA QMSR), clinical evidence generation for device approval, and post-market surveillance.
This specialization exists because medical device development follows a fundamentally different regulatory and commercial path than hospital operations or payer strategy. A consultant skilled at health system cost reduction typically has no direct experience with device classification decisions or biocompatibility testing requirements — these are genuinely distinct skill sets, not different flavors of the same expertise.
Common medtech consulting service areas include:
- Regulatory strategy and FDA submission support
- Quality systems (ISO 13485, QMSR compliance, CAPA management)
- Clinical affairs and evidence planning
- Design controls and risk management (ISO 14971)
- Global market access and in-country registration
- Cybersecurity and software-as-a-medical-device (SaMD) compliance
How to Decide Between a Generalist Firm and a Medtech Specialist
The decision usually comes down to what kind of problem you’re solving. If your challenge is broad organizational strategy, operational performance, or cross-segment positioning (for example, a health system considering a service-line expansion, or a life sciences company evaluating market entry), a firm with wide healthcare coverage may be the better fit, particularly if it also has credible life sciences experience. If your challenge is device-specific — a regulatory submission, a quality system buildout, a post-market compliance issue — a medtech specialist will almost always bring more directly applicable expertise, because these engagements require fluency in specific regulatory frameworks that generalist firms rarely maintain at depth.
Company stage matters too. Early-stage device startups building their first quality management system or preparing an initial FDA submission typically do better with boutique, startup-focused medtech specialists, while larger manufacturers managing multi-country regulatory complexity or clinical trials at scale may need a full-service firm with global reach and device-specific depth.
Evaluation Criteria
Whichever category fits your need, a few criteria apply broadly:
- Relevant track record: Ask for examples of work in your specific sub-sector or device classification, not just general healthcare or medtech experience.
- Team composition: Who will actually staff the engagement, and do they have hands-on regulatory, clinical, or quality experience rather than purely strategic backgrounds?
- Engagement model fit: Project-based, retainer, or staff augmentation — match the model to your internal capacity and the duration of the need.
- Regulatory currency: For medtech specifically, confirm the firm is current on recent FDA guidance changes (QMSR transition, cybersecurity requirements for connected devices), since these shift frequently.
- References from comparable-stage companies: A firm’s largest client isn’t necessarily the most relevant reference if your organization is a different size or stage.
Conclusion
The practical distinction between healthcare consulting firms and medtech consulting isn’t firm size or prestige — it’s whether the problem you’re solving requires broad healthcare sector knowledge or device-specific regulatory and quality expertise. Many organizations waste evaluation time comparing firms that aren’t actually competing for the same work. The more useful first step is defining the problem precisely enough to know which category you’re actually shopping in, then evaluating candidates within that category against track record, team composition, and engagement fit.
FAQs
Q1. Can a general healthcare consulting firm handle medical device regulatory work?
Some large multi-service firms have dedicated medtech practices with real regulatory depth, but many general healthcare consultancies do not. Ask specifically about FDA submission experience and named regulatory staff rather than assuming broad healthcare expertise transfers.
Q2. How much does medtech consulting typically cost compared to general healthcare consulting?
Pricing varies by scope and firm tier rather than by category alone — boutique medtech specialists and large strategy firms both range widely. Cost depends more on the specific deliverable (a single regulatory strategy session versus ongoing quality system management) than on whether the firm is a generalist or specialist.
Q3. Do medtech consulting firms also help with clinical trials for devices?
Many do, though device clinical trials differ from drug trials in scope and regulatory pathway. Firms with combined clinical and regulatory practices, or major CROs with dedicated device practices, are typically better suited to this than boutique quality-focused firms.
Q4. What’s the difference between hiring a healthcare consulting firm and hiring a healthcare consulting firm with a life sciences specialty?
A firm with a dedicated life sciences or medtech specialty typically has staff with regulatory, clinical, or scientific backgrounds specific to that sector, rather than general management consulting backgrounds applied to a healthcare client. This distinction matters more as the work gets more technical.
Q5. How do I check whether a medtech consulting firm is current on FDA requirements?
Ask directly how they’ve handled recent regulatory shifts — such as the FDA’s QMSR transition from the legacy Quality System Regulation — and request specifics rather than general assurances. A firm genuinely current on regulatory change should be able to discuss it in concrete detail.